Profiles

Keywords
Last Name
Institution

Phase I trial of oral estramustine and 3-hr infusional paclitaxel for the treatment of hormone refractory prostate cancer.

Kuzel TM, Kies MS, Wu N, Hsieh YC, Rademaker AW. Phase I trial of oral estramustine and 3-hr infusional paclitaxel for the treatment of hormone refractory prostate cancer. Cancer Invest. 2002; 20(5-6):634-43.

View in: PubMed

collapse authors with profiles